AHL Investment Management’s Teladoc Health TDOC Stock Holding History

AHL Investment Management’s Portfolio TDOC Stock Details TDOC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-2	Closed	–	–	276
2021 Q4	$0	Buy	+2	New	+$239	﹤0.01%	330

Other funds holding TDOC

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Kinnevik AB Stockholm, Sweden $65.6M AUM 25.95% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

AHL Investment Management's TDOC Position: Q1 2022 in Review

AHL Investment Management sold out of Teladoc Health (TDOC) in Q1 2022, closing a stake of 2 shares.

AHL Investment Management first reported a position in TDOC in Q4 2021 and held it in 1 quarter. The position peaked at $0 in Q4 2021. 679 funds tracked by Wall St. Rank hold TDOC as of Q1 2022.

AHL Investment Management reported no remaining Teladoc Health position as of Q1 2022 after selling out during the quarter.
AHL Investment Management sold 2 Teladoc Health shares in Q1 2022.
AHL Investment Management first reported a position in Teladoc Health in Q4 2021 and held it in 1 quarter.
AHL Investment Management's Teladoc Health position peaked at $0 in Q4 2021.
679 funds tracked by Wall St. Rank held Teladoc Health as of Q1 2022.

Based on AHL Investment Management's 13F filing for Q1 2022, filed 28 Apr 2022.